HR 5030 · 117th Congress 2021โ€“2023, ended

DIVERSE Trials Act

Latest action · Aug 16, 2021 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedAug 13, 2021
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Diversifying Investigations Via Equitable Research Studies for Everyone Trials Act or the DIVERSE Trials Act

This bill requires activities to increase diversity in clinical trials. It also expands reporting by laboratories that test for and diagnose COVID-19 and requires a study on data collection and data sharing during public health emergencies.

Specifically, the Food and Drug Administration (FDA) must issue guidance on decentralized clinical trials to promote meaningful demographic and geographic diversity in patient engagement, enrollment, and participation. Decentralized clinical trials include those executed through telemedicine or other digital technologies to allow for the remote collection and assessment of clinical trial data. The FDA may also work with foreign regulators to harmonize international regulations governing decentralized clinical trials and the use of digital health technology.

In addition, the Department of Health and Human Services (HHS) may support community education, outreach, and recruitment activities for clinical trials of treatments for conditions that disproportionately impact populations underrepresented in clinical trials.

The bill also specifies that drug or device manufacturers may provide, subject to some limits, free digital health technologies and other remuneration to patients in approved clinical trials without violating laws that address fraud and abuse in federal programs.

Furthermore, laboratories that test for and diagnose COVID-19 must report additional demographic data, including information about social determinants of health. HHS must also contract with the National Academy of Medicine to study and propose a design for an interoperable platform to facilitate data sharing during public health emergencies.

Cosponsors 54

Members who signed on, in the order they did. Signatures ran from Aug 13, 2021 to Dec 23, 2022; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
R-INLarry BucshonOriginalAug 13, 2021
D-ILBobby L. RushMay 6, 2022
D-NYBrian HigginsMay 6, 2022
D-FLDarren SotoMay 6, 2022
D-NCDeborah K. RossMay 6, 2022
D-CTJohn B. LarsonMay 6, 2022
D-CAJulia BrownleyMay 6, 2022
D-MDKweisi MfumeMay 6, 2022
R-FLMaria Elvira SalazarMay 6, 2022
D-ORSuzanne BonamiciMay 6, 2022
D-PADwight EvansJul 1, 2022
D-TXEddie Bernice JohnsonJul 1, 2022
D-CAGrace F. NapolitanoJul 1, 2022
R-FLJohn H. RutherfordJul 1, 2022
D-OHJoyce BeattyJul 1, 2022
D-DELisa Blunt RochesterJul 1, 2022
D-WAPramila JayapalJul 1, 2022
D-CASalud O. CarbajalJul 1, 2022
D-OREarl BlumenauerJul 26, 2022
D-MOEmanuel CleaverJul 26, 2022
D-HIKaiali'i KaheleJul 26, 2022
D-CASara JacobsSep 9, 2022
D-NHAnn M. KusterOct 4, 2022
R-FLBill PoseyOct 4, 2022
D-MIBrenda L. LawrenceOct 4, 2022
D-RIDavid N. CicillineOct 4, 2022
D-WADerek KilmerOct 4, 2022
D-CADoris O. MatsuiOct 4, 2022
D-CAEric SwalwellOct 4, 2022
D-MNIlhan OmarOct 4, 2022
D-MAJames P. McGovernOct 4, 2022
D-RIJames R. LangevinOct 4, 2022
D-CAJosh HarderOct 4, 2022
D-ILLauren UnderwoodOct 4, 2022
D-CAMike LevinOct 4, 2022
D-ILMike QuigleyOct 4, 2022
D-NJMikie SherrillOct 4, 2022
D-VTPeter WelchOct 4, 2022
D-CARo KhannaOct 4, 2022
D-KSSharice DavidsOct 4, 2022
D-FLSheila Cherfilus-McCormickOct 4, 2022
D-MAStephen F. LynchOct 4, 2022
D-OHTim RyanOct 4, 2022
D-AZTom O'HalleranOct 4, 2022
D-NHChris PappasOct 31, 2022
D-MIDaniel T. KildeeOct 31, 2022
D-CAMaxine WatersOct 31, 2022
D-TNSteve CohenOct 31, 2022
D-NJTom MalinowskiOct 31, 2022
D-COJason CrowDec 15, 2022
D-CAKatie PorterDec 15, 2022
D-CAMark DeSaulnierDec 15, 2022
D-WIMark PocanDec 15, 2022
D-CABarbara LeeDec 23, 2022

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Aug 13, 2021
Health Subcommittee
Referred Aug 16, 2021
HouseWays and Means Committee
Referred Aug 13, 2021
Health Subcommittee
Referred Aug 13, 2021

Actions 4

Everything that happened, newest first.

  1. Aug 16, 2021Referred to the Subcommittee on Health.
  2. Aug 13, 2021Introduced in House
  3. Aug 13, 2021Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Aug 13, 2021Referred to the Subcommittee on Health.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, section 8, Clauses 1 and 18 of the United States Constitution, to provide for the general welfare and make all laws necessary and proper to carry out the powers of Congress.

The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 146, August 13, 2021, page H4331.

Printed hearings 2

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 117-91Investing in Public Health: Legislation to Support Parents, Workers, and Research196 pagesEnergy and Commerce CommitteeJun 29, 2022
Serial No. 117-75THE FUTURE OF MEDICINE: LEGISLATION TO ENCOURAGE INNOVATION AND IMPROVE OVERSIGHT308 pagesEnergy and Commerce CommitteeMar 17, 2022

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 2706DIVERSE Trials ActIdentical billAug 10, 2021
S 4486Health Equity and Accountability Act of 2022Related billJun 23, 2022

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To improve diversity in clinical trials and data collection for COVID-19 and future public health threats to address social determinants of health.
Short Title(s) as Introduced
DIVERSE Trials Act
Diversifying Investigations Via Equitable Research Studies for Everyone Trials Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Aug 13, 2021Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.